Navigation

Announcements

Allotment of 996 Equity Shares pursuant to the Employee Stock Option Scheme (ESOS) of the Company

Appointment of Secretarial Auditors and Re-appointment of Cost Auditor

Closure of Trading Window – April 01, 2025

Additional Equity infusion in Thyrocare Laboratories (Tanzania) Limited – Joint Venture

Authority for determining material events and making disclosures in relation to Regulation 30(5) of the Listing Regulations

Appointment of Mr. Brijesh Kumar as Company Secretary, Compliance Officer and Key Managerial Personnel of the Company wef January 31, 2025.

Retirement of Mr. Ramjee Dorai as Company Secretary and Compliance Officer of the Company wef January 31, 2025.

Allotment of 1651 Equity Shares pursuant to the Employee Stock Option Scheme (ESOS) of the Company

Grant of options under Thyrocare Employees Stock Option Scheme

Intimation of allotment of equity shares of the Company under “Thyrocare Employee Stock Option Scheme”.

Equity Infusion In Thyrocare Laboratories (Tanzania) Limited

Appointment of Mr. Amey Joshi as Vice President – Human Resources

News Paper Publication

Completion Of Business Transfer Agreement With Vimta Labs Limited

Closure of Trading Window

Cessation of Independent Director

Press Release “Thyrocare Technologies Limited enters into a Business Transfer Agreement to acquire diagnostic and pathological services business of Vimta Labs Limited”.

Execution Of Business Transfer Agreement With Vimta Labs Limited.

Cessation of Independent Director

Completion of Business Transfer Agreement with Polo Labs Private Limited.

Execution of Business Transfer Agreement with Polo Labs Private Limited

Rectification Order Passed By The Income Tax Department, Mumbai For The Financial Year 2016-17

Completion of acquisition of Think Health Diagnostic Private Limited

Rectification of assessment order passed by the Navi Mumbai Municipal Corporation, Cess Department

Appointment Of Mr. Nitin Chugh As Chief Commercial Officer Of The Company W.E.F. February 22, 2024

Announcement under Regulation 30 (LODR)-Acquisition

Appointment of Mr. Rahul Guha, Managing Director and Chief Executive Officer of the Company as President – Operations and designated as Key Managerial Personnel of API Holdings Limited, Ultimate Holding Company

Closure of Trading window 

Meeting with Investors/Analysts

Intimation under Regulation 10(c) of SEBI (Share Based Employee Benefits and
Sweat Equity) Regulations, 2021

EXPLORE

LINKS

REACH US

Address: D37/1, MIDC-Turbhe, Navi Mumbai

Email: investor_relations@thyrocare.com

Tel: +9122 4125 2525 / 3090 0000

CIN – L85110MH2000PLC123882

ISIN – INE594H01019

Copyright ©2025 | Thyrocare Technologies Limited. All rights reserved.

Facebook Twitter Play Linkedin Instagram
Scroll to Top